Skip to main content

Beneficial ownership — 13D / 13G

85,706 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
RENAISSANCE TECHNOLOGIES LLC PETS Petmed Express Inc 13G 6.36% 2y
RENAISSANCE TECHNOLOGIES LLC SLCA U.S. SILICA HOLDINGS, INC. 13G 5.14% 2y
Trailblazer Sponsor Group, LLC TBMC Trailblazer Merger Corp I 13G 23.5% 2y
Phoenix Financial Ltd. GILT Gilat Satellite Networks Ltd 13D 21.19% 2y
RENAISSANCE TECHNOLOGIES LLC GASS StealthGas Inc. 13G 6.01% 2y
RENAISSANCE TECHNOLOGIES LLC APT Alpha Pro Tech Ltd 13G 5.05% 2y
William Guest Bollinger NGD New Gold Inc. 13G/A 7.7% 2y
Eric Easom ANTX AN2 Therapeutics, Inc. 13G 5.2% 2y
Dr. Stephen Mulholland INMD InMode Ltd. 13G/A 5.84% 2y
Serguei Melnik NTRB NutriBand Inc. 13G 9.26% 2y
PLATINUM EQUITY, LLC UWMC UWM Holdings Corp 13G 7.2% 2y
RA CAPITAL MANAGEMENT, L.P. MLYS Mineralys Therapeutics, Inc. 13D/A 9.99% 2y
Nan Fung Group Holdings Limited RLYB Rallybio Corp 13D/A 6.4% 2y
Samsara BioCapital, L.P. MLYS Mineralys Therapeutics, Inc. 13D/A 10.3% 2y
Nan Fung Group Holdings Limited INZY Inozyme Pharma, Inc. Common Stock 13D/A 7.2% 2y
Liberty TripAdvisor Holdings, Inc. TRIP TripAdvisor, Inc. 13D/A 21.1% 2y
CIIG Management III LLC CPTKW Crown PropTech Acquisitions 13D/A 63.6% 2y
URANIUM ENERGY CORP UROY Uranium Royalty Corp. 13D/A 14.96% 2y
MFN Partners, LP RXO RXO, Inc. 13G/A 13.3% 2y
Great Elm Group, Inc. GECC Great Elm Capital Corp. 13D/A 16.1% 2y
TPG GP A, LLC HOUS Anywhere Real Estate Inc. 13D/A 8.8% 2y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 61.86% 2y
Cano Health, Inc. MSPR MSP Recovery, Inc. 13D/A 35.6% 2y
REH Company DINO HF Sinclair Corp 13D/A 13.3% 2y
OCO Capital GP LLC GEME Pacific North of South EM Equity Active ETF 13G/A 4.94% 2y
WHITMORE BRADFORD T SLSN Solesence, Inc. 13D/A 63.7% 2y
Michael Jonas ZDGE Zedge, Inc. 13D/A 14.2% 2y
Coliseum Capital Management, LLC GMS GMS Inc. 13D/A 6.6% 2y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 7.1% 2y
Carlyle Group Inc. JSPR Jasper Therapeutics, Inc. 13D/A 7.1% 2y
Strategic Value Investors LP BFIN BankFinancial Corporation 13D 5.2% 2y
Ionic Ventures, LLC PRSO Peraso Inc. 13G 9.9% 2y
I.B.F Management Ltd. ADXS Advaxis, Inc. 13D/A 71.63% 2y
Paul Saunders, Jr. APT Alpha Pro Tech Ltd 13G/A 0.4% 2y
ADAGE CAPITAL PARTNERS GP, L.L.C. CRBP Corbus Pharmaceuticals Holdings, Inc. 13G 7.7% 2y
Deep Track Capital, LP IVVD Invivyd, Inc. 13G 7.56% 2y
Mitchell P. Kopin NVVE Nuvve Holding Corp. 13G 8.9% 2y
RA CAPITAL MANAGEMENT, L.P. CRBP Corbus Pharmaceuticals Holdings, Inc. 13G 4.1% 2y
Point72 Asset Management, L.P. ANNX Annexon, Inc. 13G 6.2% 2y
PERCEPTIVE ADVISORS LLC RYTM Rhythm Pharmaceuticals, Inc. 13G 5.5% 2y
RA CAPITAL MANAGEMENT, L.P. ATXS Astria Therapeutics, Inc. Common Stock 13G 8.1% 2y
ICAHN CARL C JBLU Jetblue Airways Corp 13D 9.91% 2y
Polus Capital Management Ltd SDRL SEADRILL Ltd 13G/A 0.3% 2y
VANGUARD GROUP INC SMAR Smartsheet Inc. 13G/A 10.01% 2y
VANGUARD GROUP INC OPI Office Properties Income Trust 13G/A 10.04% 2y
VANGUARD GROUP INC OMF OneMain Holdings, Inc. 13G/A 10.17% 2y
T. Rowe Price Investment Management, Inc. CPK Chesapeake Utilities Corp 13G/A 10.1% 2y
VANGUARD GROUP INC BIIB Biogen Inc. 13G/A 10.02% 2y
VANGUARD GROUP INC KBH Kb Home 13G/A 10.26% 2y
PRICE T ROWE ASSOCIATES INC /MD/ KYMR Kymera Therapeutics, Inc. 13G/A 10.1% 2y